These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 26606133

  • 1. Roemerine Improves the Survival Rate of Septicemic BALB/c Mice by Increasing the Cell Membrane Permeability of Staphylococcus aureus.
    Yin S, Rao G, Wang J, Luo L, He G, Wang C, Ma C, Luo X, Hou Z, Xu G.
    PLoS One; 2015; 10(11):e0143863. PubMed ID: 26606133
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice.
    Yang Y, Qian M, Yi S, Liu S, Li B, Yu R, Guo Q, Zhang X, Yu C, Li J, Xu J, Chen W.
    PLoS One; 2016; 11(2):e0149460. PubMed ID: 26926145
    [Abstract] [Full Text] [Related]

  • 3. RIP-V improves murine survival in a sepsis model by down-regulating RNAIII expression and α-hemolysin release of methicillin-resistant Staphylococcus aureus.
    Ma B, Zhou Y, Li M, Yu Q, Xue X, Li Z, Da F, Hou Z, Luo X.
    Pharmazie; 2015 Feb; 70(2):81-7. PubMed ID: 25997246
    [Abstract] [Full Text] [Related]

  • 4. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan.
    Ahn JY, Song JY, Yun YS, Jeong G, Choi IS.
    FEMS Immunol Med Microbiol; 2006 Mar; 46(2):187-97. PubMed ID: 16487300
    [Abstract] [Full Text] [Related]

  • 5. Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis.
    Alp E, Gozukucuk S, Canoz O, Kirmaci B, Doganay M.
    BMC Infect Dis; 2004 Oct 18; 4():43. PubMed ID: 15491501
    [Abstract] [Full Text] [Related]

  • 6. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW, Nimmo GR, Daly DA, Le TT, Pearson JC, Tan HL, Robinson JO, Collignon PJ, McLaws ML, Turnidge JD, Australian Group on Antimicrobial Resistance.
    Commun Dis Intell Q Rep; 2014 Dec 31; 38(4):E309-19. PubMed ID: 25631593
    [Abstract] [Full Text] [Related]

  • 7. Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.
    Coombs GW, Daley DA, Thin Lee Y, Pearson JC, Robinson JO, Nimmo GR, Collignon P, Howden BP, Bell JM, Turnidge JD, Australian Group on Antimicrobial Resistance.
    Commun Dis Intell Q Rep; 2016 Jun 30; 40(2):E244-54. PubMed ID: 27522136
    [Abstract] [Full Text] [Related]

  • 8. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
    Viallon A, Marjollet O, Berthelot P, Carricajo A, Guyomarc'h S, Robert F, Zeni F, Bertrand JC.
    Am J Emerg Med; 2007 Oct 30; 25(8):880-6. PubMed ID: 17920971
    [Abstract] [Full Text] [Related]

  • 9. Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections.
    Aguinagalde L, Díez-Martínez R, Yuste J, Royo I, Gil C, Lasa Í, Martín-Fontecha M, Marín-Ramos NI, Ardanuy C, Liñares J, García P, García E, Sánchez-Puelles JM.
    J Antimicrob Chemother; 2015 Sep 30; 70(9):2608-17. PubMed ID: 26142477
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
    Park YS, Shin WS, Kim SK.
    J Antimicrob Chemother; 2008 Jan 30; 61(1):163-8. PubMed ID: 17967852
    [Abstract] [Full Text] [Related]

  • 11. Future strategies for treating Staphylococcus aureus bloodstream infections.
    Naber CK.
    Clin Microbiol Infect; 2008 Mar 30; 14 Suppl 2():26-34. PubMed ID: 18226087
    [Abstract] [Full Text] [Related]

  • 12. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
    Patel MV, De Souza NJ, Gupte SV, Jafri MA, Bhagwat SS, Chugh Y, Khorakiwala HF, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2004 Dec 30; 48(12):4754-61. PubMed ID: 15561853
    [Abstract] [Full Text] [Related]

  • 13. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G, Moellering RC.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [Abstract] [Full Text] [Related]

  • 14. A pilot study of an anti-MRSA bio-engineered lacteal complex (anti-MRSA BLC) in a murine septicemia model.
    Stoff JA, Nix DE, DeYoung DW.
    Immunopharmacol Immunotoxicol; 2006 Jun 01; 28(4):601-7. PubMed ID: 17190737
    [Abstract] [Full Text] [Related]

  • 15. Activity of antibacterial protein from maggots against Staphylococcus aureus in vitro and in vivo.
    Zhang Z, Wang J, Zhang B, Liu H, Song W, He J, Lv D, Wang S, Xu X.
    Int J Mol Med; 2013 May 01; 31(5):1159-65. PubMed ID: 23467515
    [Abstract] [Full Text] [Related]

  • 16. Successful selection of an infection-protective anti-Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models.
    Ohsawa H, Baba T, Enami J, Hiramatsu K.
    Microbiol Immunol; 2015 Apr 01; 59(4):183-92. PubMed ID: 25659598
    [Abstract] [Full Text] [Related]

  • 17. Isovalerylshikonin, a new resistance-modifying agent from Arnebia euchroma, supresses antimicrobial resistance of drug-resistant Staphylococcus aureus.
    He JM, Sun SC, Sun ZL, Chen JT, Mu Q.
    Int J Antimicrob Agents; 2019 Jan 01; 53(1):70-73. PubMed ID: 30176356
    [Abstract] [Full Text] [Related]

  • 18. Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus.
    Li Z, Mao R, Teng D, Hao Y, Chen H, Wang X, Wang X, Yang N, Wang J.
    Sci Rep; 2017 Sep 21; 7(1):12124. PubMed ID: 28935900
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.
    Rouse MS, Rotger M, Piper KE, Steckelberg JM, Scholz M, Andrews J, Patel R.
    Antimicrob Agents Chemother; 2005 Aug 21; 49(8):3187-91. PubMed ID: 16048923
    [Abstract] [Full Text] [Related]

  • 20. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
    Aydeniz Ozansoy F, Cevahir N, Kaleli İ.
    Mikrobiyol Bul; 2015 Jan 21; 49(1):1-14. PubMed ID: 25706726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.